BioNTech
- Pfizer/BioNTech say preliminary findings “do not indicate the need for a new vaccine to address the emerging variants”
- Companies “prepared to respond” if new strain is shown to be able to evade the immunity of the vaccine
Latest updates
Recommended
© 2024 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.